2019
DOI: 10.1016/j.preteyeres.2018.11.006
|View full text |Cite
|
Sign up to set email alerts
|

Return of function after CNS axon regeneration: Lessons from injury-responsive intrinsically photosensitive and alpha retinal ganglion cells

Abstract: Link to publication on Research at Birmingham portal General rights Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes permitted by law. • Users may freely distribute the URL that is used to identify this publication. • Users may download and/or print one copy of the publication from th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
21
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 21 publications
(21 citation statements)
references
References 150 publications
0
21
0
Order By: Relevance
“…[46][47][48] Other studies have reported that aRGCs and ipRGCs are tolerant to optic nerve injury, and one explanation for this may be their high mTOR activity. 11,18,49,50 Therefore, future studies may focus on identifying the survival mechanisms in these two RGC subtypes. Furthermore, overexpression of OPN or melanopsin in RGCs boosts mTOR signaling to promote axon regeneration.…”
Section: Discussionmentioning
confidence: 99%
“…[46][47][48] Other studies have reported that aRGCs and ipRGCs are tolerant to optic nerve injury, and one explanation for this may be their high mTOR activity. 11,18,49,50 Therefore, future studies may focus on identifying the survival mechanisms in these two RGC subtypes. Furthermore, overexpression of OPN or melanopsin in RGCs boosts mTOR signaling to promote axon regeneration.…”
Section: Discussionmentioning
confidence: 99%
“…An even larger effect can be achieved when the PI3K/AKT/ mTOR pathway is activated by deleting Phosphatase and Tensin homolog (PTEN) or Tuberous Sclerosis Complex 1 (TSC1) (Park et al, 2008;de Lima et al, 2012). However, the number of RGCs responding to these treatments is small, less than 10% of the total RGCs in the retina (Duan et al, 2015;Berry et al, 2018). In addition, overactivation of the mTOR pathway by PTEN deletion causes undesired secondary effects such as an increase in RGC size (Duan et al, 2015) and even cancer (Xie et al, 2015).…”
Section: Introductionmentioning
confidence: 99%
“…Six subtypes of ipRGCs have been described to express at least small amounts of melanopsin (also known as Opn4), and are named M1-M6 [31,32]. Antibodies against melanopsin allow the identification of the large majority of ipRGCs, preferentially M1–M3, because M4 (which corresponds to the ON αRGC subtype [33,34]), M5 [35], and M6 [32] express less Opn4 than M1–M3 and are difficult to identify with standard immunohistochemistry [31,32,36,37,38,39,40]. In rats, the population of m + RGCs constitute approximately 2.5 and 2.7% of the pigmented and albino RGC populations, respectively [13,14,19,41,42].…”
Section: Introductionmentioning
confidence: 99%